Ezintsha-Clinical Research Site ( Site 3907)

Johannesburg, Gauteng 2193

0 studies enrolling now · 1 studies all time

What they study most

HIV-1 Infection

Studies at this site

• A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051) — Running, not enrolling